Wan-long L. Chuang
100 Tzyou Road, 807
Kaohsiung, KHQ, Taiwan
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 384 publications
HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.
Journal: Hepatology international
Published: June 09, 2026
Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence-Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: June 02, 2026
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.
Journal: The New England journal of medicine
Published: May 28, 2026
Editorial: Liver and Non-Liver Outcomes Between Different Subtypes of Steatotic Liver Disease.
Journal: Alimentary pharmacology & therapeutics
Published: May 18, 2026
Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: The Kaohsiung journal of medical sciences
Published: April 15, 2026
Predicting non-alcoholic fatty liver disease (NAFLD) using machine learning algorithms: Evidence from a large-scale community cohort in Taiwan.
Journal: Bioscience trends
Published: March 01, 2026
Hidden asymptomatic breakthrough infection in a proof-of-concept longitudinal study on SARS-CoV-2 vaccine recipients.
Journal: Journal of biomedical science
Published: February 11, 2026
Association Between ADH1B rs1229984 Genetic Polymorphism and Hepatic Steatosis Assessed by CT Attenuation: A Mediation Analysis of Central Obesity in MASLD.
Journal: Journal of gastroenterology and hepatology
Published: February 06, 2026
A First-in-Human study of AHB-137, an unconjugated antisense oligonucleotide, in healthy subjects and patients with chronic hepatitis B.
Journal: Hepatology (Baltimore, Md.)
Published: January 22, 2026
Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.
Journal: The Kaohsiung journal of medical sciences
Published: January 13, 2026
Corrigendum to "Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study" [JHEP Reports 2025 7(10) 101516].
Journal: JHEP reports : innovation in hepatology
Published: December 30, 2025
Ambient nitrogen oxides exposure associated with hepatic steatosis in patients with chronic hepatitis B.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: December 24, 2025
Last Updated: 09/26/2026